Ms. Catherine Faye Mattie, APN Nurse Practitioner - Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 56th Medical Group, 7219 Litchfield Road, Luke Air Force Base, AZ 85309 Phone: 623-856-4032 Fax: 623-856-8803 |
News Archive
According to new international research, just less than one per cent of the population is naturally protected against developing chronic coronary artery diseases.
The number of cases of invasive pneumococcal disease (IPD) in children has fallen since the introduction of a new vaccine a year ago. Enhanced surveillance by the UK's Health Protection Agency has shown that cases of IPD caused by the seven major types of the pneumococcus bacteria which the new pneumococcal conjugate vaccine (PCV) protects against have gone down by almost 50%.
Actavis Group, the international generic pharmaceuticals company, today announced that its US subsidiary, Actavis Inc, has entered into a binding letter of intent (LOI) with QRxPharma Limited to commercialize MoxDuo IR in the United States.
While some Democrats maintain that bipartisan health care reform work still has potential, others seem to be hedging their bets. The Christian Science Monitor reports that "In all likelihood, (White House Chief of Staff Rahm Emanuel and press secretary Robert Gibbs) are engaging in creative ambiguity, designed to send signals to multiple audiences - friend and foe - and keep options open as long as possible."
An experimental drug, LX211 (LUVENIQ-; oral voclosporin), may become the first approved oral treatment capable of modifying the course of uveitis, a group of serious eye conditions inevitably associated with either severe vision loss or substantial morbidity from steroid use.
› Verified 4 days ago